Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rinvoq for Acute Anterior Uveitis in Axial Spondyloarthritis
NCT07018206Phase 4Not yet recruiting
- Sponsor
- CARE Arthritis
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of upadacitinib in acute anterior uveitis (AAU), sponsored by CARE Arthritis. Planned start May 2026; status: not yet recruiting.
02
Drugs
upadacitinib
03
Conditions
acute anterior uveitis (AAU)
Beyond the preview
Go deeper on NCT07018206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07018206.